Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- COVID-19:
-
Coronavirus disease 2019
- SARS-CoV:
-
Severe acute respiratory syndrome, coronavirus
- MERS-CoV:
-
Middle East respiratory syndrome, coronavirus
- UTR:
-
Untranslated region
- ORF:
-
Open reading frame
- NSP:
-
Non-structural protein
- ACE-2:
-
Angiotensin-converting enzyme
- RT-PCR:
-
Reverse transcriptase-polymerase chain reaction
- qRT-PCR:
-
Real time RT-PCR
- RT-LAMP:
-
Reverse transcriptase loop-mediated PCR
- LFA:
-
Lateral flow assay
- PRNT:
-
Plaque reduction neutralization test
- LSPR:
-
Localized surface plasmon resonance
- PPT:
-
Plasmonic photothermal
- RDT:
-
Rapid diagnostic test
- CT:
-
Computerized tomography
- WHO:
-
World Health Organization
- CDC:
-
Chinese Disease Center
References
Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, Jeong SJ, Kim JH, Ku NS, Yeom JS, Roh J, Ahn MY, Chin BS, Kim YS, Lee H, Yong D, Kim HO, Kim S, Choi JY (2020) Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci 35(14):e149
Aimes RT, Zijlstra A, Hooper JD, Ogbourne SM, Sit ML, Fuhs S, Antalis TM (2003) Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. J Thromb Haemost 89(3):561–572
Assiri A, Al-Tawfiq JA, Al-Rabeeah AA et al (2013) Epidemiological, demographical, and clinical characteristics of 47 case of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13:752–761
Bantia S, Arnold CS, Parker CD, Upshaw R, Chand P (2006) Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antivir Res 69(1):39–45
Baron SA, Devaux C, Colson P, Raoult D, Rolain JM (2020) Teicoplanin an alternative drug for the treatment of coronavirus COVID-19. Int J Antimicrob Agents 55(4):105944
Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS et al (2015) Development of prototype filovirus recombinant antigen immunoassays, viral hemorrhagic fever consortium. J Infect Dis 212(Suppl 2):S359–S367
Broughton JP, Deng X, Yu G et al (2020) CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol 38(7):870–874
Bruning AHL, Leeflang MMG, Vos JMBW et al (2017) Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis. Clin Infect Dis 65(6):1026–1032
Burnouf T, Seghatchian J (2014) Ebola virus convalescent blood products: where we are now and where we may need to go. Transfus Apher Sci 51(2):120–125
Cai XF, Chen J, Long QX, Deng HJ, Liu P, Wang DQ (2020) A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of coronavirus disease 2019. J Infect Dis 222(2):189–193
Cameron CE, Oh HS, Moustafa IM (2010) Expanding knowledge of P3 proteins in the poliovirus lifecycle. Future Microbiol 5(6):867–881
Cao B (2020) A trial of remdesivir in adults with severe covid 19. ClinicalTrials.gov 21(1):422
Carr AC, Maggini S (2017) Vitamin C and immune function. Nutrients 9(11):1211
Carter L, Garner L, Smoot J, Li Y, Zhou Q, Saveson C, Liu C (2020) Assay techniques and test development for COVID-19 diagnosis. ACS Central Sci 6:591–605
Chan JF, Choi GK, Tsang AK, Tee KM, Lam HY, Yip CC (2015) Development and evaluation of novel real-time reverse transcription-PCR Assays with locked nucleic acid probes targeting leader sequences of human-pathogenic Coronaviruses. J Clin Microbiol 53:2722–2726
Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S et al (2020a) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221–236
Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH (2020b) improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol 58(5):e00310–e00320
Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, Tsoi HW (2020c) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395(10223):514–523
Chen X Y, QiuLW,Pan Y X, Wen K, Hao W, Zhang LY, Wang YD, Liao ZY, Hua X,(2004), Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol, 42 (6):2629−2635
Chen Q, Li J, Deng Z, Xiong W, Wang Q, Hu YQ (2010) Comprehensive detection and identification of seven animal coronaviruses and human respiratory coronavirus 229E with a microarray hybridization assay. Intervirology 53(2):95–104
Chen L, Liu W, Zhang Q, Xu K, Ye G, Wu W et al (2020a) RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microb Infect 9(1):313–319
Chen L, Xiong J, Bao L, Shi Y (2020b) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20(4):398–400
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020c) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513
Chu CM, Cheng VC, Hung IF et al (2004) Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59(3):252–256
Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y (2020) Molecular diagnosis of a novel Coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 66(4):549–555
Chung M, Bernheim A, Mei X et al (2020) CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 295(1):202–207
Cordes AK, Heim A (2020) Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV), using an open access protocol for the Panther Fusion. J Clin Virol 125:104305
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25(3):2000045
Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98(12):6895–6900
Deluca, MD, McElroy WD (1981) Proceedings of the symposium on bioluminescence and chemiluminescence: basic chemistry and analytical applications
Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA et al (2020) Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost 18(6):1517–1519
Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, Calfee CS (2017) Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195(3):331–338
Fehrenbach H (2001) Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2:33
Furuta Y, Komeno T, Nakamura T (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93(7):449–463
Gao J, Tian Z, Yang X (2020a) Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends 14(1):72–73
Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Zhu Y, Liu Y,. Wang X, Wang L (2020b) Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 92(7):791–796
Graci JD, Cameron CE (2006) Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol 16(1):37–48
Graham RL, Donaldson EF, Baric RS (2013) A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol 11(12):836–848
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A et al (2020) Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med 382(24):2327–2336
Guilder VHD, Vrana KE, Freeman WM (2008) Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 44(5):619–626
Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203(2):631–637
Hayden F (2009) Developing new antiviral agents for influenza treatment: what does the future hold. Clin Infect Dis 48:S3–S13
Hemida MG (2019) Middle East respiratory syndrome coronavirus and the one health concept. PeerJ 7:e7556
Heurich A, Winkler HH, Gierer S, Liepold T, Jahn O, Pöhlmann S (2014) TMPRSS2 and ADAM17 cleave ACE-2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88:1293–1307
Hoffmann M, Kleine-Weber H, Simon Schroeder S, Kruger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE-2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H et al (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382(10):929–936
Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262–1278
Huang J, Sun Y, Liu Y, Xiao H, Zhuang S (2012) Development of a loop-mediated isothermal amplification method for rapid detection of caprine arthritis-encephalitis virus proviral DNA. Arch Virol 157(8):1463–1469
Huang P, Liu T, Huang L, Liu H, Lei M, Xu W (2020) Use of chest CT in combination with negative RT-PCR assay for the 2019 novel Coronavirus but high clinical suspicion. Radiology 295(1):22–23
Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW et al (2011) Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 52(4):447–456
Isacsson AT, Wettermark G (1974) Anal Chim Acta 68:339
Iwai M, Horiuchi M (2009) Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT 1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis. Hypertens Res 32(7):533–536
Iwata S, Shibata Y, Kawada J, Hara S, Nishiyama Y, Morishima T et al (2006) Rapid detection of Epstein-Barr virus DNA by loop-mediated isothermal amplification method. J Clin Virol 37:128–133
Jenkins MJ, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS et al (2015) The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211(1):80–90
Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G (2020) Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 12(4):372
Jones H (2020) The importance of diagnostic testing for COVID-19. Infect Dis Hub
Juurlink DN (2020) Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ 192(17):E450–E453
Kan B, Wang M, Jing H, Xu H, Jiang X, Yan M et al (2005) Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol 79:11892–11900
Khalili JS, Zhu H, Mak N, Yan Y, Zhu Y (2020) Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19. J Med Virol 92(7):740–746
Kim HS, Lee KE, Oh JH, Jung CS, Choi D, Kim Y, Noh H (2016a) Cardiac arrest caused by nafamostat mesilate. Kidney Res Clin Prac 35(3):187–189
Kim UJ, Won EJ, Kee SJ et al (2016b) Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome. Antivir Ther 21(5):455–459
Kim M, Lee JH, Nam JM (2019) Plasmonic photothermal nanoparticles for biomedical applications. Adv Sci 6:1900471
Koczula KM, Gallotta A (2016) Lateral flow assays. Essays Biochem 60(1):111–120
Kohno S, Kida H, Mizuguchi M, Himada SJ (2010) Efficacy and safety of intravenous peramivir for the treatment of seasonal influenza. Antimicrob Agents Chemother 54:4568–4574
Konrad R, Eberle U, Dangel A, Treis B, Berger A, Bengs K (2020) Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany. Euro Surveill 25(9):2000173
Kuebler WM, Parthasarathi K, Wang PM, Bhattacharya J (2000) A novel signaling mechanism between gas and blood compartments of the lung. J Clin Invest 105(7):905–913
Kumar N, Upadhyay LSB (2018) 19 – Polymeric gels for biosensing applications. In: Pal K, Banerjee I (eds) Polymeric gels, pp 487–503
Lee SH, Baek YH, Kim YH, Choi YK, Song MS, Ahn JY (2016) One-pot reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) for detecting MERS-CoV. Front Microbiol 7:2166
Lee JH, Cheglakov Z, Yi J, Cronin TM, Gibson KJ, Tian BZ, Weizmann Y (2017) Plasmonic photothermal gold bipyramid nanoreactors for ultrafast real-time bioassays. J Am Chem Soc 139:8054–8057
Lim YX, Ng YL, Tam JP, Liu DX (2016) Human coronaviruses: a review of virus-host interactions. Diseases (Basel, Switzerland) 4(3):26
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ et al (2020) Case of the index patient who caused tertiary transmission of COVID- 19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 35(6):e79
Liu Y, Liu Y, Diao B, Feifei R et al (2020) Diagnostic indexes of a rapid IgG/IgM combined antibody test for SARS-CoV-2. Medxriv 20044883
Lu CL, Murakowski DK, Bournazos S, Schoofs T, Sarkar D, Halper-Stromberg A et al (2016) Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science 352(6288):1001–1004
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565–574
Lurie N, Saville M, Hatchett R, Halton J (2020) Perspective: developing COVID-19 vaccines at pandemic speed. N Engl J Med 382:1969–1973
Marano G, Vaglio S, Pupella S, Facco G, Catalano L, Liumbruno GM et al (2016) Convalescent plasma: new evidence for an old therapeutic tool. Blood Transfus 14(2):152–157
Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema K-J, Coppes RP, Engedal N, Mari M, Reggiori F (2018) Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14(8):1435–1455
McGonagle D, Sharif K, O’Regan A, Bridgewood C (2020) Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. Autoimmun Rev 19(6):102537
Moore S C, Penrice-Randal R, Alruwaili M et al (2020) Amplicon based MinION sequencing of SARS-CoV-2 and metagenomics characterisation of nasopharyngeal swabs from patients with COVID-19. medRxiv:20032011
Mori Y, Nagamine K, Tomita N, Notomi T (2001) Detection of loop mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun 289:150–154
Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, Shi PY (2020) A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. bioRxiv:109546
Nagamine K, Hase T, Notomi T (2002) Accelerated reaction by loop mediated isothermal amplification using loop primers. Mol Cell Probs 16:223–229
Nielsen K, Yu WL, Kelly L, Bermudez R, Renteria T, Dajer A, Gutierrez E, Williams J, Algire J, de Eschaide ST (2008) Development of a lateral flow assay for rapid detection of bovine antibody to Anaplasma marginale. J Immunoass Immunochem 29(1):10–18
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T (2000) Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28:E63
Okba NMA et al (2020) Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis 26(7):1478–1488
Olsson T, Brunius G, Carlsson HE, Thore A (1979) Luminescence immunoassay (LIA): a solid-phase immunoassay monitored by chemiluminescence. J Immunol Methods 25(2):127–135
Omrani AS, Saad MM, Baig K et al (2014) Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 14(11):1090–1095
Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323(18):1775–1776
Pan F, Ye T, Sun P, Gui S, Liang B, Li L (2020) Time course of lung changes on chest CT during recovery from 2019 novel Coronavirus (COVID-19) pneumonia. Radiology 295(3):715–721
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S (2020) Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 79:104212
Park SE (2020) Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr 63(4):119–124
PathSensors, Inc (2020) Announced the development of a SARSCoV-2 biosensor. PathSensorsInc 443:887–4005
Pene F, Merlat A, Vabret A et al (2003) Coronavirus 229E-related pneumonia in immuno compromised patients. Clin Infect Dis 37(7):929–932
Perera RA et al (2020) Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill 25(16):2000421
Qiu G, Gai Z, Tao Y, Schmitt J, Kullak-Ublick GA, Wang J (2020) Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection. ACS Nano 14(5):5268–5277
Ren LL, Wang YM, Wu ZQ et al (2020), Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 133(9):1015–1024
Rohrman BA, Leautaud V, Molyneux E, Richards-Kortum RRA (2012) Lateral flow assay for quantitative detection of amplified HIV-1 RNA. PLoS One 7(9):e45611
Rosa S, Santos WC (2020) Clinical trials on drug repositioning for COVID-19 treatment. Revistapanamericana de salud publica = Pan Am J Public Health 44:e40
Rosseau S, Selhorst J, Wiechmann K, Leissner K, Maus U, Mayer K et al (2000) Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines. J Immunol 164(1):427–435
Rynes R (1997) Antimalarial drugs in the treatment of rheumatological diseases. Rheumatology 36(7):799–805
Santos R, Ferreira A, Verano-Braga T, Bader M (2013) Angiotensin-converting enzyme2, angiotensin-(1-7) and Mas: new players of renin-angiotensin system. J Endocrinol 216(2):R1–R17
Sassolas A, Blum LJ, Leca-Bouvier BD (2011) Immobilization strategies to develop enzymatic biosensors. Biotechnol Adv 30(3):489–571
Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A (2006) New insights into the antiviral effects of chloroquine. Lancet Infect Dis 6(2):67–69
Schrezenmeier E, Dorner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155–166
Schultz KR, Gilman AL (1997) The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease. Leuk Lymphoma 24(3–4):201–210
Sheahan TP, Sims AC, Graham RL et al (2017) Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 9(396):3653–3653
Sheahan TP, Sims AC, Leist SR et al (2020) Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 11:222–222
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J (2020) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 20:425–434
Shulla A, Taylor HS, Subramanya G, Jincun Z, Perlman S, Gallagher TA (2011) trans-membrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol 85:873–882
Soler M, Huertas CS, Lechuga LM (2019) Label-free plasmonic biosensors for point-of-care diagnostics: a review. Expert Rev Mol Diagn 19:71–81
Son JH, Cho B, Hong S, Lee SH, Hoxha O, Haack AJ, Lee LP (2015) Ultrafast photonic PCR. Light Sci Appl 4:e280
Tan R (2020) COVID-19 diagnostics explained. Asian Scientist
Thai HTC, Le MQ, Vuong CD, Parida M, Minekawa H, Notomi T, Hasebe F, Morita K (2004) Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of Severe Acute Respiratory Syndrome coronavirus. J Clin Microbiol 42(5):1956–1961
Tian S, Hu W, Niu L et al (2020) Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 15(5):700–704
Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME (2003) Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41(3):392–397
To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC, Chan JMC (2020) Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis:ciaa149
University of Oxford (2020) Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
Vaarala MH, Porvari KS, Kellokumpu S, Kyllönen AP, Vihko PT (2001) Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. J Pathol 193(1):134–140
Vassilara F (2018) A rare case of human coronavirus 229E associated with acute respiratory distress syndrome in a healthy adult. Case Rape Infect Dis 2018:6796839
Villalaín J (2010) Membranotropic effects of arbidol, a broad anti-viral molecule, on phospholipid model membranes. J Phys Chem B 114(25):8544–8554
Villar J, Belda J, Añón JM et al (2016) Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial. Trials 1(7):342
Villar J, Ferrando C, Martínez D et al (2020) Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 8(3):267–276
Wang M, Cao R, Zhang L et al (2020a) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269–271
Wang Y, Kang H, Liu X, Tong Z (2020b) Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J Med Virol 92(6):538–539
Williams VR, Scholey JW (2018) Angiotensin-converting enzyme 2 and renal disease. Curr Opin Nephrol Hypertens 27(1):35–41
Wit DE, Feldmann F, Cronin J et al (2020) Prophylactic,phylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A 117:6771–6776
Wolf H, Haus M, Leser U et al (1984) New developments in nucleic acid hybridization. IARC Sci Publ 63:373–391
World Health Organization (2020a) WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients
World Health Organization (2020b) Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance
Wu Z, McGoogan M (2020a) Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 50(5):e13233
Wu Z, McGoogan JM (2020b) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2648
Wu F et al (2020) A new coronavirus associated with human respiratory disease in China. Nature 579:265–269
Xi G, Peng G, Quan W, Boyang C, Bin L (2014) Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus. J Microbiol Biotechnol 24(10):1445–1454
Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J (2020a) Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology 200343
Xie X et al (2020b) An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27(5):841–848.e3
Yao X, Ye F, Zhang M et al (2020a) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis:ciaa237
Yao XH, Li TY, He ZC et al (2020b) A pathological report of three COVID-19 cases by minimally invasive autopsies 49:E009
Yousefifard M, Zali A, Mohamed Ali K, MadaniNeishaboori A, Zarghi A, Hosseini M, Safari S (2020) Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch Acad Emerg Med 8(1):e45
Zhang F, Abudayyeh OO, Gootenberg JS (2020a) A protocol for detection of COVID-19 using CRISPR diagnostics. Broad Institute of MIT and Harvard v, 20200321
Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R (2020b) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, NY) 368(6489):409–412
Zhang L, Yan X, Fan Q et al (2020c) D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 18(6):1324–1329
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sinha, V. et al. (2021). Current Challenges for the Effective Management of the COVID-19 Pandemic. In: Asea, A.A.A., Kaur, P. (eds) Coronavirus Therapeutics – Volume II. Advances in Experimental Medicine and Biology, vol 1353. Springer, Cham. https://doi.org/10.1007/978-3-030-85113-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-85113-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-85112-5
Online ISBN: 978-3-030-85113-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)